63 citations
,
January 1971 in “Acta Medica Scandinavica” This study found that replenishment of iron stores after phlebotomy-induced remission in porphyria cutanea tarda led to biochemical relapse, suggesting that reducing iron stores may be crucial for maintaining remission.
June 2026 in “Scholars Journal of Medical Case Reports” This retrospective study found that intravenous iron therapy significantly improved hair loss in most patients with iron deficiency, achieving complete resolution in 60%, partial improvement in 36%, and persistent hair loss in only 4% after three months.
In this study, oral iron replacement showed some evidence of improving chronic telogen effluvium in iron deficient women, though further research is required to confirm the association.
February 2018 in “The American Journal of Gastroenterology” This study observed that intravenous ferric carboxymaltose did not inhibit the drug-induced reduction of inflammatory activity in patients with inflammatory bowel disease, as indicated by lower CRP levels.
January 2018 in “Journal of Crohn s and Colitis” This study found that high-dose intravenous ferric carboxymaltose may reduce inflammatory activity in patients with inflammatory bowel disease and iron deficiency anaemia, as evidenced by decreased CRP levels and improved clinical disease indices.